Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected. Tre-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al. J Infect 2022 Feb 15. pii: S0163-4453(22)00073.

Read + Share

Amedeo Smart

Independent Medical Education

Tre-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al. Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected. J Infect 2022 Feb 15. pii: S0163-4453(22)00073.
PMID: 35181372